MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation

髓母细胞瘤 医学 肿瘤科 放射治疗 内科学 转移 室管膜瘤 癌症研究 病理 癌症
作者
Kohei Fukuoka,Jun Kurihara,Makiko Mori,Yuki Arakawa,Ema Yoshioka,Tomoko Shofuda,Yuko Matsushita,Yuko Hibiya,Satoko Honda,Atsuko Nakazawa,Chikako Kiyotani,Naoki Kagawa,Kai Yamasaki,Ryõ Andõ,Dai Keino,Yosuke Miyairi,Atsushi Sasaki,Ryo Nishikawa,Isao Date,Motoo Nagane
出处
期刊:Neuro-oncology advances [Oxford University Press]
卷期号:3 (Supplement_6): vi16-vi17
标识
DOI:10.1093/noajnl/vdab159.061
摘要

Abstract Background: One of the most significant challenges is a reduction in the dose of craniospinal irradiation (CSI) in patients with medulloblastoma to minimize neurological sequelae. However, a North American clinical trial failed to show the prognostic non-inferiority of lower-dose irradiation compared to that associated with standard-dose radiation therapy for non-metastatic medulloblastomas. A European retrospective study revealed that whole chromosomal aberration signatures (WCASs) are a potential prognostic factor in Group 3/4 medulloblastoma without metastasis, but whether the molecular signature has the same clinical impact in patients treated with lower-dose CSI remains unknown. Methods: We conducted DNA methylation analysis using an Illumina Infinium Human Methylation EPIC BeadChip array to investigate molecular prognostic markers in 23 medulloblastoma patients who were registered in the Japan Pediatric Molecular Neuro-Oncology Group and treated with lower-dose CSI relative to standard treatment. A WCAS was defined as the presence of at least two of three chromosomal changes as follows: chromosome (chr) 7 gain, chr 8 loss, and chr 11 gain.Results: All patients presented with no residue or a residual tumor smaller than 1.5 cm2 after surgery without metastasis. The median age at onset was 6.9 years, and the median follow-up period was 80.6 months. CSI was delivered at a median dose of 18.0 Gy. Regarding molecular subgrouping, there were 5 WNT, 2 SHH, 1 Group 3, and 15 Group 4 medulloblastomas. Seven patients with Group 3/4 medulloblastomas showed WCASs and had significantly better prognosis than those without the alteration (5-year progression-free survival 100% vs. 63%, p = 0.046). Two late relapses occurred at 89 and 115 months after diagnosis, respectively, and one of these patients presented with a WCAS.Conclusion: WCAS may be a molecular prognostic marker not only in patients with medulloblastoma treated with standard-dose CSI but also in those treated with lower-dose irradiation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李永畅发布了新的文献求助10
刚刚
叔叔喜欢高科技完成签到,获得积分20
刚刚
爱听歌不二完成签到 ,获得积分10
1秒前
在水一方的应助被乐观的书白采纳,获得10
1秒前
小魏哥完成签到,获得积分10
1秒前
顾矜的应助被拉姆采纳,获得10
1秒前
1秒前
李安全完成签到,获得积分10
1秒前
2秒前
null的应助被小鱼小鱼采纳,获得10
2秒前
华仔的应助被阿林采纳,获得10
2秒前
2秒前
酷波er的应助被学术垃圾桶采纳,获得10
2秒前
h11的应助被Hino采纳,获得10
2秒前
xjc发布了新的文献求助10
2秒前
Likz发布了新的文献求助10
2秒前
2秒前
辛勤的鹰完成签到 ,获得积分10
2秒前
万万发布了新的文献求助10
3秒前
万佳俊完成签到,获得积分10
3秒前
xingjj完成签到,获得积分10
3秒前
Kuan_Jiyong发布了新的文献求助10
3秒前
3秒前
3秒前
儒雅小蜜蜂完成签到 ,获得积分10
3秒前
4秒前
04d发布了新的文献求助10
4秒前
搞怪的松鼠完成签到,获得积分10
4秒前
鸭梨味的稀饭完成签到 ,获得积分10
4秒前
飞快的羊青完成签到,获得积分10
4秒前
内向易文发布了新的文献求助10
4秒前
ruia168的应助被遇见飞儿采纳,获得10
4秒前
暴富预赵发布了新的文献求助10
4秒前
5秒前
美丽冬卉完成签到,获得积分10
5秒前
高贵一德完成签到,获得积分10
5秒前
个性的依玉完成签到,获得积分10
5秒前
向左转发布了新的文献求助10
5秒前
5秒前
369ninja的应助被xhgxfh采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159581
求助须知:如何正确求助?哪些是违规求助? 9555100
关于积分的说明 21724719
捐赠科研通 7749543
什么是DOI,文献DOI怎么找? 3427281
关于科研通互助平台的介绍 2552278
邀请新用户注册赠送积分活动 2471619